Home
Advertisement & Sponsorship Options
Download Our Media Kit
Continued Medical Education
Cancer A – Z
Drug Developmemt Technologies
A Novel Technology based on Somatic Hypermutation (SHM)
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
The Network
The Episodes
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
The Onco’Zine Brief
The Episodes
National Advertising
Agenda
Membership
Join Today
Event Agenda
Video
Careers
Search
About
Advertise
Advisory Board
Contact Us
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Onco'Zine
Advertisement #1
Home
Advertisement & Sponsorship Options
Download Our Media Kit
Continued Medical Education
Cancer A – Z
Drug Developmemt Technologies
A Novel Technology based on Somatic Hypermutation (SHM)
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
The Network
The Episodes
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
The Onco’Zine Brief
The Episodes
National Advertising
Agenda
Membership
Join Today
Event Agenda
Video
Careers
Home
Regulatory Updates
Page 10
Regulatory Updates
Regulatory Updates
MIRASOL Trial: Elahere® Shows Survival Benefit in FRα-Positive Platinum-Resistant Ovarian Cancer
Editorial Team
-
May 4, 2023
EMA Validates Authorization for Dostarlimab + Chemo in Advanced/Recurrent Endometrial Cancer
UK Cancer Patients to Receive the First Immunotherapy for Advanced Cervical Cancer
Retifanlimab Approved for Treatment of Metastatic/Recurrent Locally Advanced Merkel Cell Carcinoma
FDA Priority Review of NDA for Nirogacestat for the Treatment of Rare Desmoid Tumors
FDA Grants Accelerated Approval for Venetoclax in Newly-Diagnosed Acute Myeloid Leukemia...
Peter Hofland, Ph.D
-
November 24, 2018
European Commission Approves Pegfilgrastim Biosimilar Pelmeg
Peter Hofland, Ph.D
-
November 24, 2018
FDA Approval of Emapalumab Marks Significant Improvement in Primary HLH Induction...
Peter Hofland, Ph.D
-
November 24, 2018
Increased Popularity of E-cigarettes Results in Alarming Rise of Young Smokers
Danielle Garcia
-
November 17, 2018
European Medicines Agency Validates and Grants Accelerated Assessment for Quizartinib in...
Danielle Garcia
-
November 5, 2018
New Data Supports Use of Real-World Evidence to Assess Long-term Impact...
Peter Hofland, Ph.D
-
July 10, 2018
Why Do We Need a Right-to-Try Bill in America?
Jane Orient
-
June 12, 2018
U.S. FDA Grants Accelerated Approval for Neoadjuvant use of Pertuzumab in...
Editorial Team
-
October 1, 2013
Accelerated Approval of Pertuzumab for Neoadjuvant Treatment in High-risk, HER2-Positive Early...
Editorial Team
-
September 13, 2013
Timesaving, Subcutaneous Formulation of Trastuzumab for the Treatment of HER2-positive Breast...
Editorial Team
-
September 3, 2013
1
...
9
10
11
12
Page 10 of 12
LATEST NEWS
Study Shows that Only a Small Percentage of Cancer Research Funding Directly Benefits Patients
Editorial Team
-
June 1, 2023
How a Medical Recoding May Limit Cancer Patients’ Options for Breast Reconstruction
Rachana Pradhan
-
May 31, 2023
Mammograms at 40? Breast Cancer Screening Guidelines Spark Fresh Debate
Ronnie Cohen
-
May 30, 2023
It’s Time to Stop Talking About Cellular Therapy Disparities and Take Action
Jeffery J Auletta, MD
-
May 22, 2023
Testing Novel Cancer Agents Beyond the Final Frontier
Editorial Team
-
May 22, 2023
X